All Type of News
742 combined drugs to exit from NHI reimbursement by Nov.
In the wake of the government's saving plans for the drug expenditures the total 742 non-prescription combined drugs will be converted to the non-NHI reimbursement from coming Nov.
The MOHW took a meeting of "NHI P...
Daewoong's pharmaceutical bulk production ranks first in 2005
Daewoong Pharm ranked first in the domestic pharmaceutical bulk output in 2005, helped by robust demand of its vitamin preparation CoQ10, the Korea Pharmaceutical Manufacturers Association (KPMA) said recently.
Th...
Civic group seeking further price reduction of new drug
Following the recent insurance price reduction of AstraZeneca's Iressa from 62,010 won per tablet to 55,003 won, a civic group said it plans to call on the government to lower the prices of innovative drugs, to help e...
Legislation of new drug pricing policy delayedThe enactment of a proposed drug pricing and reimbursement policy has been postponed for two days after the economic ministers' meeting on July 22.
The Ministry of Health and...
|
Korean women mostly worried about uterus cervix cancer.
An on-line survey through a website of www.uteruscervixcance.kr conducted by the Korea Society of Ob & Gyn revealed that of 7 most frequent women cancers the uterus cervix cancer became the top disease the Korean wome...
Mr. Lee Hui-yeol named Asia Pacific head of Bayer.Mr. Lee Hui-yeol (41 years old), a Korean, was named as the head of the new merger company between Bayer and Schering in charge of the Asia and Pacific Operation covering Korea,...
|
Daewoong first-quarter sales increase 12%
Daewoong Pharm said its first-quarter (April-June) sales rose a better-than-expected 12.4 percent from a year ago, driven by robust sales of flagship products such as Ursa and Almetec (almesartan medoxomil), analysts ...
Health functional foods market thrives
The domestic health functional foods market has grown exponentially in the past few years, backed by the nation's well-being boom.
Health foods makers and pharmaceutical firms are all rushing toward the burgeoning ...
How to make exceptional provisions for unified distribution system.
The drug distribution industry sensitively concerns how to revise the exceptional provisions in the Working Rules of the Pharmaceutical Affairs Act for the unified drug distribution system.
At present the drug whol...
KIHSA suggests government's bigger role for drug risk management
The government will have to reinforce inspecting and tracking the risk management of drugs in a bid to prevent their harmful effects in an effective manner, an expert said at a seminar.
The government should place ...
